Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Net Cash Flow: 2018-2019

Historic Net Cash Flow for DiaMedica Therapeutics (DMAC) over the last 2 years, with Dec 2019 value amounting to -$858,000.

  • DiaMedica Therapeutics' Net Cash Flow fell 106.64% to -$858,000 in Q4 2019 from the same period last year, while for Dec 2019 it was -$12.9 million, marking a year-over-year decrease of 183.65%. This contributed to the annual value of -$1.5 million for FY2024, which is 733.51% down from last year.
  • Latest data reveals that DiaMedica Therapeutics reported Net Cash Flow of -$858,000 as of Q4 2019, which was down 148.56% from $1.8 million recorded in Q3 2019.
  • DiaMedica Therapeutics' 5-year Net Cash Flow high stood at $12.9 million for Q4 2018, and its period low was -$14.1 million during Q1 2019.
  • Over the past 2 years, DiaMedica Therapeutics' median Net Cash Flow value was -$321,500 (recorded in 2019), while the average stood at $316,250.
  • The largest annual percentage gain for DiaMedica Therapeutics' Net Cash Flow in the last 5 years was 196.66% (2019), contrasted with its biggest fall of 362.54% (2019).
  • Over the past 2 years, DiaMedica Therapeutics' Net Cash Flow (Quarterly) stood at $12.9 million in 2018, then crashed by 106.64% to -$858,000 in 2019.
  • Its Net Cash Flow stands at -$858,000 for Q4 2019, versus $1.8 million for Q3 2019 and $215,000 for Q2 2019.